Načítá se...
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2
[Image: see text] Covalently acting inhibitors constitute a large and growing fraction of approved small-molecule therapeutics as well as useful tools for a variety of in vitro and in vivo applications. Here, we aimed to develop a covalent antagonist of CC chemokine receptor 2 (CCR2), a class A GPCR...
Uloženo v:
| Vydáno v: | J Med Chem |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2021
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958898/ https://ncbi.nlm.nih.gov/pubmed/33600174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jmedchem.0c01137 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|